Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Eur J Clin Invest ; 49(1): e13040, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30368775

RESUMO

BACKGROUND: Fructose intake may lead to hyperuricaemia, which is associated with increased risk and progression of kidney disease. We aimed to explore the acute effects of fructose loading from different sources, with and without a pizza, on levels of serum uric acid in patients with chronic kidney disease (CKD), type 2 diabetes (T2D) without CKD, and in healthy subjects (HS). METHODS: The study included six HS, and three CKD stage 4-5 and seven T2D patients. Drinks consumed were blueberry drink (17.5 g fructose), Coca-Cola (18 g fructose) and fructose drink (35 g fructose). The drinks were also combined with pizza, in total six interventions. Serum samples were collected fasting and 30, 60, 90 and 120 minutes after intake and also 240 minutes after drink + pizza, and analysed for fructose, uric acid and triglycerides. Postprandial responses were explored using repeated-measure ANOVA. RESULTS: Baseline serum uric acid levels were increased in CKD (P = 0.037). There were significant differences in serum fructose and serum uric levels over time between drinks and drinks + pizza for all groups (P < 0.001 and P < 0.05, respectively). The highest peak in serum fructose followed the fructose drink interventions and the lowest the blueberry drink. The fructose drink interventions gave the highest responses in serum uric acid and the lowest responses followed the blueberry drink. Triglycerides increased following pizza interventions (P < 0.001). CONCLUSIONS: Intake of fructose increases serum uric acid. The fructose intake via a blueberry drink induced lowest increase and thus may be protective.


Assuntos
Frutose/farmacologia , Edulcorantes/farmacologia , Ácido Úrico/metabolismo , Idoso , Análise de Variância , Bebidas , Diabetes Mellitus Tipo 2/sangue , Feminino , Frutose/administração & dosagem , Humanos , Hiperuricemia/sangue , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Insuficiência Renal Crônica/sangue , Triglicerídeos/metabolismo
2.
Kidney Blood Press Res ; 42(5): 877-885, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29161688

RESUMO

BACKGROUND/AIMS: Beta-trace protein (BTP) is a low-molecular-weight molecule, which may be used to assess residual renal function (RRF) in dialysis patients. Here we evaluated the influence of hemodialysis (HD) and hemodiafiltration (HDF) on plasma BTP, and analyzed the inter- and intra-individual variability of plasma BTP over time in HD and peritoneal dialysis (PD) patients. METHODS: In 12 prevalent HD patients, the effect of a single session of low-flux HD, high-flux HD and HDF on plasma BTP was studied. Blood samples were taken at baseline, after 120 and 240 minutes, and at the start of the next dialysis session. In 13 HD patients and 10 PD patients, inter- and intra-individual variability over three months was studied (monthly and weekly, respectively). Plasma BTP was measured using a nephelometric method. RESULTS: No significant decrease in plasma BTP was seen following a session of low-flux HD. Both high-flux HD and HDF resulted in a significant decrease immediately after dialysis (22% and 61% median decrease, respectively). A significant reduction of the molecule persisted only in HDF and a significant decrease (-15%) was still found immediately before the start of the next dialysis session. In both HD and PD patients, the reproducibility over time was excellent with intra-class correlation coefficient of 0.96 (0.93-0.99) and 0.92 (0.86-0.99) respectively. In a small cohort of PD patients, fair agreement existed between mGFR (average of renal urea and creatinine clearance from a 24 hours urine collection) and the BTP-based GFR estimation. CONCLUSION: BTP is a stable marker and a promising tool for RRF estimations in PD and HD patients. In patients receiving HDF, plasma levels of BTP should be interpreted with caution.


Assuntos
Taxa de Filtração Glomerular , Oxirredutases Intramoleculares/sangue , Lipocalinas/sangue , Diálise Renal/métodos , Adulto , Idoso , Biomarcadores/sangue , Hemodiafiltração , Humanos , Rim/fisiologia , Pessoa de Meia-Idade , Diálise Peritoneal , Reprodutibilidade dos Testes , Fatores de Tempo
3.
Scand J Clin Lab Invest ; 73(2): 154-60, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23336588

RESUMO

The consumption of fructose has increased dramatically during the last few decades and parallels the epidemics of obesity, metabolic syndrome, diabetes and chronic kidney disease (CKD). Fructose occurs naturally e.g. in fruit and in honey (rich in this monosaccharide) and as sucrose (table sugar). The effects of fructose have been attributed to the transient increases in serum uric acid levels during its metabolism. Recent research, also in CKD patients, has linked fructose to dysmetabolism of lipids, glucose and oxidative radicals. However, a general consensus of the potentially harmful effects of fructose is lacking. We improved a sensitive inulin assay for fructose measurement in serum and plasma and tested its accuracy in an acute experiment following consumption of pure fructose in controls. In addition, fructose and uric acid were analyzed postprandially during 240 min in six maintenance hemodialysis (HD) patients and nine healthy subjects consuming 190 ml cream/75 g sucrose in a fasting state. Whereas the fructose levels reached a maximum level after 60 min in controls they had not even started to decrease at 240 min in HD-patients. Likewise, while uric acid levels remained stable in controls they increased by 10% in HD patients at 240 min following the meal. In conclusion, a glucose and fat rich meal is associated with delayed absorption and/or metabolism of fructose in HD patients as well as increased serum uric acid levels.


Assuntos
Frutose/sangue , Diálise Renal , Insuficiência Renal/sangue , Adulto , Idoso , Glicemia , Estudos de Casos e Controles , Gorduras na Dieta/metabolismo , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Período Pós-Prandial , Insuficiência Renal/terapia , Ácido Úrico/sangue , Adulto Jovem
4.
Nutrients ; 13(9)2021 Sep 04.
Artigo em Inglês | MEDLINE | ID: mdl-34578989

RESUMO

Inflammation plays a role in development of diabetic complications. The postprandial state has been linked to chronic low grade inflammation. We therefore aimed to investigate the acute effects of fructose loading, with and without a pizza, on metabolic and inflammatory markers in patients with type 2 diabetes (T2D) (n = 7) and in healthy subjects (HS) (n = 6), age 47-76 years. Drinks consumed were blueberry drink (18 g fructose), Coca-Cola (17.5 g fructose), and fructose drink (35 g fructose). The levels of glucose, insulin, insulin-like growth factor binding protein-1 (IGFBP-1) and inflammatory markers: Interleukin-6 (IL-6), Monocyte chemoattractant protein-1 (MCP-1), Interleukin-18 (IL-18), Intercellular Adhesion Molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and bacterial lipopolysaccharides (LPS) were analyzed in blood. The postprandial responses were assessed using Wilcoxon's matched-pairs test, Friedman's ANOVA and Mann-Whitney U test. There was no difference in baseline levels of inflammatory markers between the groups. In T2D, MCP-1 decreased following blueberry drink and Coca-Cola (p = 0.02), Coca-Cola + pizza and fructose + pizza (p = 0.03). In HS, IL-6 increased following blueberry + pizza and fructose + pizza (p = 0.03), there was a decrease in MCP-1 following blueberry drink and Coca-Cola (p = 0.03), and in ICAM-1 following blueberry + pizza (p = 0.03). These results may indicate a role for MCP-1 as a link between postprandial state and diabetes complications, however further mechanistic studies on larger population of patients with T2D are needed for confirmation of these results.


Assuntos
Frutose/efeitos adversos , Inflamação/induzido quimicamente , Idoso , Biomarcadores/sangue , Glicemia/análise , Bebidas Gaseificadas/efeitos adversos , Quimiocina CCL2/sangue , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/metabolismo , Feminino , Frutose/administração & dosagem , Sucos de Frutas e Vegetais , Humanos , Inflamação/sangue , Insulina/sangue , Molécula 1 de Adesão Intercelular/sangue , Interleucina-18/sangue , Interleucina-6/sangue , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Molécula 1 de Adesão de Célula Vascular/sangue
5.
PLoS One ; 8(9): e72934, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24039826

RESUMO

The brown bear (Ursus arctos) hibernates for 5 to 6 months each winter and during this time ingests no food or water and remains anuric and inactive. Despite these extreme conditions, bears do not develop azotemia and preserve their muscle and bone strength. To date most renal studies have been limited to small numbers of bears, often in captive environments. Sixteen free-ranging bears were darted and had blood drawn both during hibernation in winter and summer. Samples were collected for measurement of creatinine and urea, markers of inflammation, the calcium-phosphate axis, and nutritional parameters including amino acids. In winter the bear serum creatinine increased 2.5 fold despite a 2-fold decrease in urea, indicating a remarkable ability to recycle urea nitrogen during hibernation. During hibernation serum calcium remained constant despite a decrease in serum phosphate and a rise in FGF23 levels. Despite prolonged inactivity and reduced renal function, inflammation does not ensue and bears seem to have enhanced antioxidant defense mechanisms during hibernation. Nutrition parameters showed high fat stores, preserved amino acids and mild hyperglycemia during hibernation. While total, essential, non-essential and branched chain amino acids concentrations do not change during hibernation anorexia, changes in individual amino acids ornithine, citrulline and arginine indicate an active, although reduced urea cycle and nitrogen recycling to proteins. Serum uric acid and serum fructose levels were elevated in summer and changes between seasons were positively correlated. Further studies to understand how bears can prevent the development of uremia despite minimal renal function during hibernation could provide new therapeutic avenues for the treatment of human kidney disease.


Assuntos
Hibernação/fisiologia , Estações do Ano , Ursidae/metabolismo , Adaptação Biológica , Adulto , Idoso , Idoso de 80 Anos ou mais , Aminoácidos/sangue , Aminoácidos/metabolismo , Animais , Creatinina/sangue , Creatinina/metabolismo , Feminino , Fator de Crescimento de Fibroblastos 23 , Frutose/sangue , Humanos , Masculino , Metaboloma , Pessoa de Meia-Idade , Ureia/sangue , Ureia/metabolismo , Ácido Úrico/sangue , Ácido Úrico/metabolismo , Ursidae/sangue
6.
Clin Chim Acta ; 411(23-24): 2079-82, 2010 Dec 14.
Artigo em Inglês | MEDLINE | ID: mdl-20837002

RESUMO

AIM: Accelerated atherosclerosis is a characteristic feature of chronic kidney disease (CKD). CD36 is a scavenger receptor which contributes to foam cell formation, an early crucial step in atherosclerosis development. Recently, a soluble form of CD36 (sCD36) has been discovered. The aim of the study was to develop an ELISA method for quantitative sCD36 evaluation and to measure it in a cohort of CKD stage 5 patients. METHOD: A novel monoclonal antibody-based sandwich ELISA for sCD36 evaluation was developed and verified by repeated optimization procedures. Serum concentration of sCD36 was then analyzed in a cohort of 228 CKD stage 5 patients prior to dialysis initiation. Additionally, samples from a control group of 73 healthy, age and gender-matched subjects were evaluated. RESULTS: The novel CD36 ELISA assay had a recovery of at least 90%, and intra- and inter-assay variability of 6 and 11%, respectively. Concentration of serum sCD36 in CKD patients was significantly increased as compared to controls, and associated with the use of HMG-CoA reductase inhibitors (statins) and the presence of diabetes mellitus (DM). Patients above the 75th percentile of sCD36 concentration were at increased risk of 3-year cardiovascular mortality, as compared to the rest of the cohort [HR 2.85 (1.09-7.59) p=0.03]. CONCLUSION: For the first time, sCD36 was assessed quantitatively in a group of patients and showed associations with DM, CKD, and statin use. Furthermore, the concentration of sCD36 predicted cardiovascular mortality in CKD stage 5 patients.


Assuntos
Anticorpos Monoclonais/imunologia , Antígenos CD36/sangue , Antígenos CD36/química , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/mortalidade , Ensaio de Imunoadsorção Enzimática/métodos , Diálise Renal , Adulto , Idoso , Idoso de 80 Anos ou mais , Antígenos CD36/imunologia , Antígenos CD36/metabolismo , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/complicações , Estudos de Casos e Controles , Doença Crônica/terapia , Estudos de Coortes , Feminino , Regulação da Expressão Gênica , Humanos , Nefropatias/sangue , Nefropatias/complicações , Nefropatias/terapia , Masculino , Pessoa de Meia-Idade , Prognóstico , Solubilidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA